By an overwhelming majority, the House of Representatives voted yesterday to approve a limited federal shield law that would enable reporters to protect the confidentiality of their sources from compulsory disclosure under most circumstances. See the record of the October 16 House debate here.
The White House issued a strong statement of opposition and suggested the President would veto the reporter’s shield bill if adopted by Congress as written. “The legislation would make it extremely difficult to prosecute cases involving leaks of classified information and would hamper efforts to investigate and prosecute other serious crimes,” the October 16 statement said (pdf).
Nuclear weapons budgeting is like agreeing to buying a house without knowing the sales price, the mortgage rate, or the monthly payment.
Employing a living approach to evidence synthesis, disseminated at a national level, is a streamlined way to enable evidence-based decision-making nationwide.
By providing essential funding mechanisms, the Bioeconomy Finance Program will reduce the risks inherent in biotechnology innovation, encouraging more private sector investment.
While the U.S. has made significant advancements and remained a global leader in biotechnology over the past decade, the next four years will be critical in determining whether it can sustain that leadership.